BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 12542895)

  • 61. Antibodies to oxidized low-density lipoproteins and angiographically assessed coronary artery disease in white patients.
    Rossi GP; Cesari M; De Toni R; Zanchetta M; Maiolino G; Pedon L; Ganzaroli C; Maiolino P; Pessina AC
    Circulation; 2003 Nov; 108(20):2467-72. PubMed ID: 14581399
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Circulating malondialdehyde-modified LDL and atherogenic lipoprotein profiles measured by nuclear magnetic resonance spectroscopy in patients with coronary artery disease.
    Miyazaki T; Shimada K; Sato O; Kotani K; Kume A; Sumiyoshi K; Sato Y; Ohmura H; Watanabe Y; Mokuno H; Daida H
    Atherosclerosis; 2005 Mar; 179(1):139-45. PubMed ID: 15721020
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease.
    Lehtimäki T; Lehtinen S; Solakivi T; Nikkilä M; Jaakkola O; Jokela H; Ylä-Herttuala S; Luoma JS; Koivula T; Nikkari T
    Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):23-7. PubMed ID: 9888862
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Oxidised LDL/LDL-cholesterol ratio and coronary artery calcification in haemodialysis patients.
    Asamiya Y; Yajima A; Tsuruta Y; Otsubo S; Nitta K
    Nutr Metab Cardiovasc Dis; 2013 Jul; 23(7):619-27. PubMed ID: 22608251
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Carbamyl adducts on low-density lipoprotein induce IgG response in LDLR-/- mice and bind plasma autoantibodies in humans under enhanced carbamylation.
    Kummu O; Turunen SP; Wang C; Lehtimäki J; Veneskoski M; Kastarinen H; Koivula MK; Risteli J; Kesäniemi YA; Hörkkö S
    Antioxid Redox Signal; 2013 Oct; 19(10):1047-62. PubMed ID: 23311771
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Serum high-density lipoprotein-cholesterol levels modify the association between plasma levels of oxidatively modified low-density lipoprotein and coronary artery disease in men.
    Zhang B; Bai H; Liu R; Kumagai K; Itabe H; Takano T; Saku K
    Metabolism; 2004 Apr; 53(4):423-9. PubMed ID: 15045686
    [TBL] [Abstract][Full Text] [Related]  

  • 67. High density- and beta-lipoprotein screening for risk of coronary artery disease in the context of new findings on reverse cholesterol transport.
    Levinson SS
    Ann Clin Lab Sci; 2002; 32(2):123-36. PubMed ID: 12017193
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Assessment of IgG antibodies to oxidized LDL in patients with acute coronary syndrome.
    Laczik R; Szodoray P; Veres K; Szomják E; Csípo I; Sipka S; Shoenfeld Y; Szekanecz Z; Soltész P
    Lupus; 2011 Jun; 20(7):730-5. PubMed ID: 21505011
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Autoantibodies against modified low-density lipoproteins in coronary artery disease.
    Tornvall P; Waeg G; Nilsson J; Hamsten A; Regnström J
    Atherosclerosis; 2003 Apr; 167(2):347-53. PubMed ID: 12818418
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Low density lipoprotein distribution by flotation characteristics in normal conditions and in dyslipoproteinemias].
    Medvedeva NV; Morozkin AD; Goroshkova IN; Ruuge EK; Shcherbakova IA
    Vopr Med Khim; 1989; 35(3):36-41. PubMed ID: 2773382
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antibodies to malondialdehyde oxidized low-density lipoproteins predict long term cardiovascular mortality in high risk patients.
    Maiolino G; Pedon L; Cesari M; Frigo AC; Barisa M; Rossitto G; Seccia TM; Zanchetta M; Rossi GP
    Int J Cardiol; 2013 Sep; 168(1):484-9. PubMed ID: 23102599
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Increased autoantibodies against oxidized low-density lipoprotein in coronary circulation in patients with coronary spastic angina.
    Ogawa H; Soejima H; Takazoe K; Miyamoto S; Kajiwara I; Shimomura H; Sakamoto T; Yoshimura M; Kugiyama K; Kimura M; Yasue H
    Angiology; 2001 Mar; 52(3):167-74. PubMed ID: 11269779
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Autoantibodies against oxidatively modified low-density lipoprotein in patients with Behçet's disease.
    Orem A; Cimşit G; Değer O; Vanizor B; Karahan SC
    Dermatology; 1999; 198(3):243-6. PubMed ID: 10393445
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Apolipoproteins in the discrimination of atherosclerotic burden and cardiac function in patients with stable coronary artery disease.
    Patel JV; Abraheem A; Creamer J; Gunning M; Hughes EA; Lip GY
    Eur J Heart Fail; 2010 Mar; 12(3):254-9. PubMed ID: 20089519
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Increased levels of autoantibodies against copper-oxidized low density lipoprotein, malondialdehyde-modified low density lipoprotein and cardiolipin in patients with rheumatoid arthritis.
    Cvetkovic JT; Wållberg-Jonsson S; Ahmed E; Rantapää-Dahlqvist S; Lefvert AK
    Rheumatology (Oxford); 2002 Sep; 41(9):988-95. PubMed ID: 12209031
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pre-eclampsia and serum antibodies to oxidised low-density lipoprotein.
    Branch DW; Mitchell MD; Miller E; Palinski W; Witztum JL
    Lancet; 1994 Mar; 343(8898):645-6. PubMed ID: 7509433
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Low levels of IgG autoantibodies against the apolipoprotein B antigen p210 increases the risk of cardiovascular death after carotid endarterectomy.
    Asciutto G; Dias NV; Edsfeldt A; Alm R; Fredrikson GN; Gonçalves I; Nilsson J
    Atherosclerosis; 2015 Apr; 239(2):289-94. PubMed ID: 25682025
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunochemical characterization of purified human oxidized low-density lipoprotein antibodies.
    Virella G; Koskinen S; Krings G; Onorato JM; Thorpe SR; Lopes-Virella M
    Clin Immunol; 2000 May; 95(2):135-44. PubMed ID: 10779407
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Malondialdehyde-Modified LDL IgG Antibody Levels and Indices of Cardiac Function in Valvular Heart and Coronary Artery Disease Patients.
    Rahsepar AA; Mirzaee A; Moodi F; Moohebati M; Tavallaie S; Khorashadizadeh F; Mottahedi B; Esfehanizadeh J; Azari A; Khojasteh R; Mousavi S; Paydar R; Amini M; Ghayour-Mobarhan M; Ferns GA; Sahebkar A
    Med Princ Pract; 2015; 24(5):424-31. PubMed ID: 26139161
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Measurement of asialylated LDL in the blood of patients with coronary artery disease by antibody-lectin sandwich assay.
    Mcdowell A; Young IS; Wisdom GB
    Ann Clin Biochem; 2001 Sep; 38(Pt 5):499-508. PubMed ID: 11587128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.